|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Jan 31, 2023
|
Q3 FY2022
As of Oct 31, 2022
|
Q2 FY2022
As of Jul 31, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 31, 2022
|
Q3 FY2021
As of Oct 31, 2021
|
Q2 FY2021
As of Jul 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Goods and service tax receivable | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Goods and service tax receivable | ||||||||||||||||||||
| Marketable security | ||||||||||||||||||||
| Prepaid and other assets | ||||||||||||||||||||
| Deferred financing cost, current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Accrued interest income | ||||||||||||||||||||
| Deferred financing cost, non-current | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accounts payable and accrued expenses - related parties | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Loans payable - related parties | ||||||||||||||||||||
| Accrued interest - related parties | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Accrued Interest on loan | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 219,784,477 issued and outstanding as of March 31, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, 1 share, at cost | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | ||||||||||||||||||||
Loading...
